Petra Seibold

9PUBLICATIONS
82CO-AUTHORS
Radiation therapyPredictive and prognostic markersPanel data analysisEpidemiological methodsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 13, 2026
Circadian genotypes in PER3 and time of prostate cancer radiotherapy interact to affect risk of late side-effects.

|Apr 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patients.

|Mar 13, 2026
Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review.

Maxime De Vrieze, Nan Zhang, Petra Seibold

|Oct 13, 2025
Integration of Dose Surface Maps and Genetic Data Identifies the Lower Posterior Rectum as a Key Region for Toxicity after Prostate Cancer Radiotherapy.

Artemis Bouzaki, Eliana Vasquez Osorio, Sarah Kerns

|Jul 16, 2025
Cost effectiveness analysis of prostate cancer screening strategies in Germany: A microsimulation study.

Muchandifunga Trust Muchadeyi, Shuang Hao, Karla Hernandez-Villafuerte

|Mar 03, 2025
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer.

Manzur Farazi, Xin Yang, Carson J Gehl

Pageof 2

Frequent Collaborators

5 joint publications

Elena Sperk

5 joint publications

Adam Webb

5 joint publications

Ana Vega

5 joint publications

Tiziana Rancati